Eko Health

?? We are honored to announce that the FDA has cleared Eko's Low Ejection Fraction (Low EF) AI. For the first time, U.S. healthcare providers can now detect reduced ejection fraction, a key indicator of heart failure, using an Eko stethoscope during routine physical examinations. ?? Developed in collaboration with Mayo Clinic, Eko's Low EF AI marks a major milestone in the early detection of cardiovascular diseases. ??? Dr. Paul Friedman, Chair of the Department of Cardiovascular Medicine at Mayo Clinic in Rochester, remarked: "The ability to identify a hidden, potentially life-threatening heart condition using a tool that primary care and subspecialist clinicians are familiar with — the stethoscope — can help us prevent hospitalizations and adverse events. Importantly, since a stethoscope is small and portable, this technology can be used in urban and remote locations and hopefully help address care in underserved areas." ??? Connor Landgraf, co-founder and CEO of Eko Health, highlighted: "The stethoscope, the most recognizable symbol of healthcare, touches the lives of an estimated 1 billion people around the globe every year. With Eko's Low EF AI, we've transformed the icon of medicine into an AI-powered heart failure early detection tool that can help improve access to care for millions of patients at a fraction of the time and cost of echocardiography. It's been a privilege to work alongside Mayo Clinic in this groundbreaking endeavor." ?? Read the full press release here: https://lnkd.in/g6wur3Xb #healthcare #digitalhealth #AI #cardiology #health

?? We’re honored to announce Delmis Perez Castro, an Internal Medicine Resident PGY1 at NCH, as our September 2024 SENSORA? Heart Hero! Delmis’ journey from being a physician in Cuba to her first year in the NCH residency program is a testament to her dedication and resilience. Using Eko's CORE 500? Digital Stethoscope and the SENSORA? platform, she’s elevating cardiac care by detecting early signs of heart disease and delivering better care for her patients. We're proud to honor her compassionate approach and her impact on advancing heart health at NCH. Together, we're saving lives, one heartbeat at a time. ?? Read her full story here: https://lnkd.in/gQiXjrEZ ?? by Odette Fernandez Lopez #HeartHero #CardiacCare #HealthcareInnovation #EkoHealth #SENSORA #NCH #Innovation #EarlyDetection

??We are beyond honored to announce that the Eko CORE 500? Digital Stethoscope has won Gold in the 2024 International Design Excellence Awards (IDEA) Medical & Health category and also took home Best in Show! ?? This recognition places Eko alongside some of the most innovative leaders in healthcare technology, celebrated for pushing the boundaries of medical design. The CORE 500? was recognized for its seamless integration of advanced audio technology and AI-driven insights, empowering clinicians with unmatched precision in detecting heart and lung conditions. These awards reaffirm our mission to revolutionize healthcare with tools that enhance clinical practice and improve patient outcomes. A huge thank you to Y Studios for their incredible work and to the Industrial Designers Society of America (IDSA) for this amazing honor.?? #Innovation #HealthcareDesign #MedTech #IDSAIDEA #DigitalHealth #CORE500 #ProductDesign #MedicalDevices #DesignExcellence #BestInShow

???Breakthrough research from Imperial College London presented to the European Society of Cardiology highlights the transformative potential of Eko Health’s AI to identify patients at elevated risk for major cardiac events. In a pivotal study involving over 1,000 patients, Eko’s AI was shown to predict MACE—including heart attacks, heart failure, and hospitalization—as well as all-cause mortality. Patients flagged by the AI for low ejection fraction were twice as likely to experience MACE compared to those without a positive AI result. These patients also faced a 65% higher mortality rate, even after adjusting for traditional risk factors. ?? Read more: https://lnkd.in/euc-ziFW #CardiacCare #AIHealthcare #HealthTech #Innovation #HeartHealth #EkoHealth

We're live at FMX! Come meet the Eko team at booth #2104 to learn how Eko’s software, combined with advanced digital stethoscope technology, can help you detect disease earlier. Schedule a meeting with the Eko team today: https://lnkd.in/gekxXZpR #aafpfmx #familymedicine #aafp #fmx David Bakey Dean Bowerman Mike Montgomery Joe Tertel Michaela Landgraf Jason Bellet Grace Hanson Luis Perez David Heasley

?? Early detection is critical when it comes to heart failure, the leading cause of hospitalization and death in the United States that affects millions. At Eko, we're transforming heart failure detection with our FDA-cleared SENSORA? Low EF. By identifying reduced ejection fraction during routine exams, we’re enabling clinicians to catch this serious condition early, before it worsens. Time is precious in primary care, and our AI-powered solution allows for rapid, accurate assessments without disrupting workflow — delivering earlier diagnoses and better outcomes. ?? Join us at FMX 2024 (booth #2104) for a demo of SENSORA? Low EF to see how Eko’s technology can help you detect disease earlier. ??Schedule a meeting today: https://bit.ly/4ekng5s ??Learn more about heart failure: https://bit.ly/47tH4kB #FMX2024 #HeartFailure #EarlyDetection #SENSORA #EkoHealth #aafpfmx #familymedicine #aafp #fmx

Eko is ?????????? to partner with Astellas Pharma and Welldoc on DIGITIVA? — a heart failure management solution that combines Eko and Welldoc’s technologies to deliver more comprehensive, data-driven insights from the home. Now listed by the U.S. FDA as a Class I Software as a Medical Device (SaMD), DIGITIVA combines remote monitoring, personalized coaching, and expert clinical review, aiming to support intervention and help prevent acute events. #EkoHealth #HeartFailure #DigitalStethoscope #HealthcareInnovation #CORE500 #CardiologyCare

??At Eko, we're celebrating the power of telehealth and its impact on improving patient outcomes and access to care. During #TelehealthAwarenessWeek, we reaffirm our commitment to advancing telehealth technology beyond videoconferencing. With Eko’s virtual auscultation and AI-supported tools, healthcare providers can deliver accurate, confident care — anytime, anywhere. One-click live streaming for synchronous listening allows healthcare professionals to securely record, save, and share high-fidelity audio to improve confidence in clinical decision-making. ??Enhance your telehealth practice with Eko. Talk to our team today: https://lnkd.in/gN9VCPb3 #TelehealthAwarenessWeek #Telehealth #HealthcareInnovation #AccessToCare

???? Today marks the beginning of International Heart Valve Disease Awareness Week — a time to shine a light on the importance of early diagnosis and intervention for heart valve conditions. At Eko, we’re committed to advancing early detection technologies to improve patient outcomes. This week, we encourage you to refresh your knowledge on tricuspid regurgitation, one of the most common and often undiagnosed heart valve diseases. By raising awareness, we can ensure more patients receive timely care and treatment. ?? Learn more: https://bit.ly/3XEUbfl #HeartHealth #HeartValveDisease #EarlyDiagnosis #AwarenessMatters

Eko Health's AI ?????????????? ?????? ?????????????????? ???? ?????????? ?????????????? ???? ???????????????? ?????????? in a recent randomized controlled clinical trial published in Nature Medicine. Led by Dr. Demilade Adedinsewo at Mayo Clinic, the trial evaluated the performance of Eko’s recently FDA-cleared Low EF AI technology in detecting ejection fraction (EF) at several thresholds, a key metric of heart pump function typically captured using cardiac ultrasound. Involving over 1,200 participants, the study demonstrated that Eko’s Low EF AI technology enabled healthcare professionals to detect PPCM at twice the rate of traditional obstetric care. “This study represents a significant step forward in using AI to address critical healthcare challenges, particularly in underserved regions where maternal health outcomes are most at risk,” said Connor Landgraf, CEO and co-founder of Eko Health. “Our mission at Eko has always been to bridge the gap in cardiovascular care access through innovative technology. The results of this trial reinforce our commitment to providing accessible, life-saving tools to healthcare providers around the world, enabling them to detect heart disease earlier and improve patient outcomes.” Learn more: https://lnkd.in/gJB7NSxZ